Product image of Latanoprost Eg (Latanoprost) supplied by GNH India

Latanoprost Eg

Active Ingredient:
Latanoprost
Origin:
EU

Latanoprost Eg (Latanoprost)

Latanoprost, the active ingredient in Latanoprost Eg, is a prostaglandin analog presented as an ophthalmic solution for ocular use. It lowers intraocular pressure and is indicated for the treatment of open‑angle glaucoma and ocular hypertension in adults.
GNH India supplies Latanoprost Eg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Eg Labo Laboratoires Eurogenerics

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Latanoprost is a prostaglandin analog used to manage conditions that involve elevated intraocular pressure.

  • Open-angle glaucoma: reduces intraocular pressure to slow disease progression.
  • Ocular hypertension: lowers pressure to prevent conversion to glaucoma.
  • Pseudoexfoliative glaucoma: decreases intraocular pressure to control optic nerve damage.

How It Works

  • Latanoprost is a prostaglandin F2α analog that binds to FP receptors in the ciliary muscle, enhancing uveoscleral outflow of aqueous humor. By increasing this unconventional drainage pathway, the drug effectively reduces intraocular pressure, helping to protect the optic nerve from pressure‑related damage.

Side Effects

Latanoprost may cause ocular and systemic reactions, most of which are mild and reversible.

Common Side Effects

  • Eye redness: mild conjunctival hyperemia.
  • Eyelash changes: increased length, thickness, or darkness.
  • Iris pigmentation: gradual darkening of the iris.
  • Eye irritation: itching or burning sensation.
  • Blurred vision: transient visual disturbance.
  • Foreign body sensation: feeling of grit in the eye.

Serious or Rare Side Effects

  • Severe allergic reaction: swelling, rash, or difficulty breathing.
  • Uveitis: inflammation of the uveal tract.
  • Corneal edema: swelling of the cornea affecting clarity.
  • Cystoid macular edema: fluid accumulation in the macula.
  • Vision loss: sudden decrease in visual acuity.
  • Persistent ocular pain: requires immediate evaluation.

Precautions & Warnings

Before initiating Latanoprost therapy, consider the following safety measures.

  • Monitor intraocular pressure: assess response after starting treatment.
  • Assess for ocular infection: avoid use if active conjunctivitis or keratitis is present.
  • Evaluate allergy history: discontinue if hypersensitivity develops.
  • Use with caution in patients with cystoid macular edema: monitor retinal status.
  • Avoid contact lens wear during treatment: lenses may trap the solution and cause irritation.
  • Store at room temperature: keep the bottle tightly closed, protect from light and moisture.

Avoid Interactions

Latanoprost can interact with other ocular or systemic agents, influencing efficacy or safety.

Major Interactions (Avoid)

  • Concomitant use with other prostaglandin analogs: may increase risk of ocular inflammation.
  • Use with ocular anesthetic drops containing preservatives: can reduce drug absorption.

Moderate Interactions (Monitor Closely)

  • Beta‑blocker eye drops: additive intraocular pressure‑lowering effect may lead to hypotony.
  • Carbonic anhydrase inhibitor eye drops: combined therapy may enhance pressure reduction.
  • Systemic prostaglandin analogs: may increase systemic side‑effect profile.
  • Anticholinergic eye drops: potential for reduced efficacy of Latanoprost.

Frequently Asked Questions

Latanoprost Eg is an ophthalmic solution containing the prostaglandin analog latanoprost. It is prescribed to lower intraocular pressure in adults with open‑angle glaucoma or ocular hypertension, helping to prevent optic nerve damage and preserve visual function.

Latanoprost mimics prostaglandin F2α and activates FP receptors in the ciliary body. This activation increases uveoscleral outflow of aqueous humor, the alternative drainage route, thereby reducing intraocular pressure and mitigating the risk of glaucoma progression.

The dosing regimen for Latanoprost Eg is determined by the prescribing clinician. Typically, a single drop is instilled into the affected eye(s) once daily in the evening, but the exact dose and timing should follow the prescriber’s instructions.

The safety of Latanoprost in pregnancy and lactation has not been definitively established. It is classified as pregnancy category unknown, so it should only be used if the potential benefit justifies any potential risk to the fetus or infant, and under medical supervision.

To order Latanoprost Eg, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Latanoprost belongs to the prostaglandin analog class, which generally offers once‑daily dosing and a strong intraocular pressure‑lowering effect. Compared with beta‑blocker or carbonic anhydrase inhibitor drops, prostaglandin analogs often have a more favorable dosing schedule and comparable efficacy, though individual response may vary.

Latanoprost Eg should be stored at room temperature, below 25 °C. Keep the bottle tightly closed, protect it from light, and store it in its original packaging to maintain stability and potency.

Latanoprost Eg is applied as a single drop into the conjunctival sac of the affected eye(s) once daily, preferably in the evening. The patient should avoid touching the tip of the bottle to the eye or any other surface to maintain sterility.

Serious risks, though rare, include severe allergic reactions, uveitis, corneal edema, cystoid macular edema, and sudden vision loss. Patients should seek immediate medical attention if they experience intense eye pain, redness, swelling, or any sudden change in vision.

Latanoprost Eg should not be used by individuals with known hypersensitivity to latanoprost or any component of the formulation, and it is contraindicated in eyes with active intraocular inflammation or infection. Consultation with an eye care professional is essential before initiating therapy.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Latanoprost

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT